TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 13 | 34 | 41 | 8 | 18 | 203 | 53 | 
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/25/23 16:05  | 5/23/23  | PRLD | Prelude Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Chardonnet Laurent | DE | O | CFO | P | 28 | 5.50 | 0 | 5 | 13 | 42 | D | ||||||||||||||
12/12/22 09:13  | 12/8/22  | PRLD | Prelude Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Chardonnet Laurent | DE | O | CFO | P | 48 | 4.76 | 0 | 10 | 39 | 36 | D | ||||||||||||||
6/1/22 16:31  | 6/1/22  | PRLD | Prelude Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Chardonnet Laurent | DE | O | CFO | P | 42 | 4.23 | 0 | 10 | 69 | 25 | D | ||||||||||||||
1/31/20 20:44  | 1/31/20  | AXLA | Axcella Health Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chardonnet Laurent | MA | O | CFO | P | 15 | 4.94 | 0 | 3 | 451 | 4 | D | ||||||||||||||
1/28/20 18:39  | 1/24/20  | AXLA | Axcella Health Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chardonnet Laurent | MA | O | CFO | P.m | 3 | 4.93 | 0 | 1 | New | 1 | D | ||||||||||||||
11/21/08 08:03  | 11/20/08  | INCY | Incyte Corp | DE | Health | Biolab | Commercial Physical & Biologi | Chardonnet Laurent | DE | H | Vice Pre | P | 22 | 2.71 | 4 | 8 | 999% | 8 | D | -53 | -69 | -75 | -75 | -44 | -40 | -40 | -32 | 13 | 34 | 41 | 8 | 18 | 203 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |